Regulatory science for microbiome-based medicines: lessons from Pharmaceuticals and Medical Devices Agency initiatives
Trends in Biotechnology · 2026-11
DOI: 10.1016/j.tibtech.2026.10.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Biotechnology, 2026-11. Verfasst von Ryosuke Kuribayashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan; Off…. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Recent Pharmaceuticals and Medical Devices Agency initiatives for live biotherapeutic products, fecal microbiota transplantation, and phage therapy medicinal products illustrate a dialog-driven regulatory approach for microbiome-based medicines. We compare this strategy with evolving Food and Drug Administration and European Medicines Agency frameworks and identify priorities for future regulatory development and international alignment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan; Office of Regulatory Science Research, Pharmaceuticals and Medical Device…
- Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan.
Zitieren
APA
Kuribayashi, R., Nakano, A., Kawasaki, M., Hariu, A., & Sakurai, A. (2026). Regulatory science for microbiome-based medicines: lessons from Pharmaceuticals and Medical Devices Agency initiatives. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2026.10.007
Vancouver
Kuribayashi R, Nakano A, Kawasaki M, Hariu A, Sakurai A. Regulatory science for microbiome-based medicines: lessons from Pharmaceuticals and Medical Devices Agency initiatives. Trends in Biotechnology. 2026. doi:10.1016/j.tibtech.2026.10.007
BibTeX
@article{Kuribayashi2026,
author = {Kuribayashi, Ryosuke and Nakano, Ayuki and Kawasaki, Miya and Hariu, Aya and Sakurai, Akira},
title = {Regulatory science for microbiome-based medicines: lessons from Pharmaceuticals and Medical Devices Agency initiatives},
journal = {Trends in Biotechnology},
year = {2026},
doi = {10.1016/j.tibtech.2026.10.007}
}
EUVIMED